Literature DB >> 33757216

Immune classification of osteosarcoma.

Trang Le1, Sumeyye Su1, Leili Shahriyari1.   

Abstract

Tumor immune microenvironment has been shown to be important in predicting the tumor progression and the outcome of treatments. This work aims to identify different immune patterns in osteosarcoma and their clinical characteristics. We use the latest and best performing deconvolution method, CIBERSORTx, to obtain the relative abundance of 22 immune cells. Then we cluster patients based on their estimated immune abundance and study the characteristics of these clusters, along with the relationship between immune infiltration and outcome of patients. We find that abundance of CD8 T cells, NK cells and M1 Macrophages have a positive association with prognosis, while abundance of γδ T cells, Mast cells, M0 Macrophages and Dendritic cells have a negative association with prognosis. Accordingly, the cluster with the lowest proportion of CD8 T cells, M1 Macrophages and highest proportion of M0 Macrophages has the worst outcome among clusters. By grouping patients with similar immune patterns, we are also able to suggest treatments that are specific to the tumor microenvironment.

Entities:  

Keywords:  gene expression analysis ; immune pattern ; osteosarcoma

Year:  2021        PMID: 33757216      PMCID: PMC7992873          DOI: 10.3934/mbe.2021098

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  65 in total

1.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

Review 2.  Regulatory T Cells and Cancer: A Two-Sided Story.

Authors:  Kepeng Wang; Anthony T Vella
Journal:  Immunol Invest       Date:  2016-09-07       Impact factor: 3.657

3.  NK cell and macrophages confer prognosis and reflect immune status in osteosarcoma.

Authors:  Xianliang Yang; Wenbin Zhang; Panfeng Xu
Journal:  J Cell Biochem       Date:  2018-12-16       Impact factor: 4.429

4.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

Review 5.  Immune cell promotion of metastasis.

Authors:  Takanori Kitamura; Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

Review 6.  Gamma-delta (γδ) T cells: friend or foe in cancer development?

Authors:  Yijing Zhao; Chao Niu; Jiuwei Cui
Journal:  J Transl Med       Date:  2018-01-10       Impact factor: 5.531

7.  Determining cell type abundance and expression from bulk tissues with digital cytometry.

Authors:  Aaron M Newman; Chloé B Steen; Chih Long Liu; Andrew J Gentles; Aadel A Chaudhuri; Florian Scherer; Michael S Khodadoust; Mohammad S Esfahani; Bogdan A Luca; David Steiner; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Biotechnol       Date:  2019-05-06       Impact factor: 54.908

8.  Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.

Authors:  Lili Huang; Hong Chen; Yu Xu; Jianhua Chen; Zhuqing Liu; Qing Xu
Journal:  Cancer Med       Date:  2020-09-15       Impact factor: 4.452

9.  Immune classification of clear cell renal cell carcinoma.

Authors:  Sumeyye Su; Shaya Akbarinejad; Leili Shahriyari
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

View more
  7 in total

1.  Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma.

Authors:  Sunetra Das; Rupa Idate; Daniel P Regan; Jared S Fowles; Susan E Lana; Douglas H Thamm; Daniel L Gustafson; Dawn L Duval
Journal:  Commun Biol       Date:  2021-10-11

Review 2.  Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications.

Authors:  Tianyi Zhu; Jing Han; Liu Yang; Zhengdong Cai; Wei Sun; Yingqi Hua; Jing Xu
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

3.  A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration.

Authors:  Navid Mohammad Mirzaei; Sumeyye Su; Dilruba Sofia; Maura Hegarty; Mohamed H Abdel-Rahman; Alireza Asadpoure; Colleen M Cebulla; Young Hwan Chang; Wenrui Hao; Pamela R Jackson; Adrian V Lee; Daniel G Stover; Zuzana Tatarova; Ioannis K Zervantonakis; Leili Shahriyari
Journal:  J Pers Med       Date:  2021-10-15

4.  Auxiliary Segmentation Method of Osteosarcoma in MRI Images Based on Denoising and Local Enhancement.

Authors:  Luna Wang; Liao Yu; Jun Zhu; Haoyu Tang; Fangfang Gou; Jia Wu
Journal:  Healthcare (Basel)       Date:  2022-08-04

5.  Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer.

Authors:  Aparajita Budithi; Sumeyye Su; Arkadz Kirshtein; Leili Shahriyari
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

6.  Data-Driven Mathematical Model of Osteosarcoma.

Authors:  Trang Le; Sumeyye Su; Arkadz Kirshtein; Leili Shahriyari
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

7.  Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma.

Authors:  Dachang Liu; Ziwei Hu; Jie Jiang; Junlei Zhang; Chunlong Hu; Jian Huang; Qingjun Wei
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.